May 23, 2017 4:29 PM ET


Company Overview of NanoCor Therapeutics, Inc.

Company Overview

NanoCor Therapeutics, Inc. develops therapeutics for the non-invasive treatment of various cardiovascular diseases at the molecular level. The company’s Carfostin is an intracellular protein therapeutic for the treatment of chronic heart failure. Its Carfostin comprises the delivery of a therapeutic gene, protein Phosphatase-1 Inhibitor-1 (I-1) with the use of Biological NanoParticles and the self-complementary vector technology. The company was founded in 2005 and is based in Chapel Hill, North Carolina. NanoCor Therapeutics, Inc. is a former subsidiary of Asklepios BioPharmaceutical, Inc.

870 Martin Luther King Junior Boulevard

Chapel Hill, NC 27514

United States

Founded in 2005





Key Executives for NanoCor Therapeutics, Inc.

Co-Founder, Acting Chief Executive Officer and Director
Scientific Founder and Director
Scientific Founder and Board Member
Scientific Founder and Board Member
Age: 50
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NanoCor Therapeutics, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at